Human B-Lymphocyte Antigen CD19 (CD19) Protein

Proteins and Peptides

B-Lymphocyte Antigen CD19 (CD19)

E. coli

Human

Unconjugated

Molecular Weight: Calculated MW: 43.2 kDa  Observed MW (SDS-PAGE): 44 kDa
Concentration: Prior to lyophilization: 200 µg/ml
Sequence Fragment: Ala160-Lys258
Tag: N-terminal His tag and GST tag

Recombinant

> 90%

10 µg

50 µg

100 µg

200 µg

500 µg

Lyophilized To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in 20 mM Tris, 150 mM NaCl, pH 8.0. If a higher concentration is required, the product can be reconstituted directly in 20 mM Tris, 150 mM NaCl, pH 8.0, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.

WB, SDS-PAGE

Prior to lyophilization: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01% Sarcosyl, 5% Trehalose and Proclin-300.

Shipped within 5-7 working days.

Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.

No

B4,CVID3,B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12

Protein CD19

RUO

This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.